ArticleTherapeutic advances in endocrinology and metabolism2026
Parathyroid carcinoma co-occurring with parathyroid adenoma and papillary thyroid carcinoma: a rare case report with comprehensive literature review.
Article in Therapeutic advances in endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parathyroid carcinoma is a rare endocrine malignancy with unclear etiology, and its clinical manifestations are often difficult to distinguish from parathyroid adenoma. The concurrent occurrence of parathyroid carcinoma, parathyroid adenoma, and thyroid carcinoma is an extremely uncommon clinical scenario. This study retrospectively analyzed the clinical data of a 44-year-old female patient with this concurrent condition who was treated at the Department of Thyroid Surgery, China-Japan Union Hospital of Jilin University. The patient underwent radical resection of left parathyroid carcinoma (including left thyroid lobectomy with isthmusectomy and central compartment lymph node dissection), excision of right parathyroid adenoma, and partial right thyroid lobectomy. Postoperative pathological examination confirmed the diagnoses of parathyroid carcinoma, parathyroid adenoma, thyroid malignant tumor, and nodular goiter. Preoperative diagnosis of this concurrent disease is highly challenging, and intraoperative pathological examination is often required for confirmation. Given the overlapping endocrine tumor patterns, this condition may be associated with underlying multiple endocrine neoplasia syndromes. Therefore, personalized treatment strategies combining precise surgery and long-term endocrine monitoring are crucial to achieve both oncological control and correction of hormonal dysregulation. This study aims to provide useful insights for clinical practice; we also conducted a literature review summarizing the reported features, diagnostic approaches, and treatment options for this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.